• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,913.50 -582.86
( -0.75%)
Global Indices
Nasdaq
49,530.46 -142.69
(-0.29%)
Dow Jones
7,252.74 22.73
(0.31%)
Hang Seng
59,594.47 309.55
(0.52%)
Nikkei 225
10,375.34 -3.48
(-0.03%)
Forex
USD-INR
94.96 0.17
(0.17%)
EUR-INR
111.11 0.25
(0.23%)
GBP-INR
128.48 0.55
(0.43%)
JPY-INR
0.60 0.01
(1.28%)

EQUITY - MARKET SCREENER

Vivimed Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532660
INE526G01021
0.9167078
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VIVIMEDLAB
0
56.13
EPS(TTM)
Face Value()
Div & Yield %
0
2
0
 

Federal Bank consolidated net profit rises 22.92% in the March 2026 quarter
Apr 29,2026
Net profit of Federal Bank rose 22.92% to Rs 1340.97 crore in the quarter ended March 2026 as against Rs 1090.94 crore during the previous quarter ended March 2025. Total Operating Income rose 11.80% to Rs 7946.61 crore in the quarter ended March 2026 as against Rs 7107.95 crore during the previous quarter ended March 2025.

For the full year,net profit rose 4.48% to Rs 4345.30 crore in the year ended March 2026 as against Rs 4158.85 crore during the previous year ended March 2025. Total Operating Income rose 5.58% to Rs 29674.10 crore in the year ended March 2026 as against Rs 28106.08 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Total Operating Income7946.617107.95 12 29674.1028106.08 6
OPM %62.0368.13 -64.1568.65 -
PBDT1713.571433.59 20 5863.435587.83 5
PBT1713.571433.59 20 5863.435587.83 5
NP1340.971090.94 23 4345.304158.85 4